Follow-The-Filings

Security · featured owners

BEAM Beam Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 4 Owners
  • Max 2.3%
  • $708M
  • 1 new 1 add 2 reduce

BEAM (Beam Therapeutics Inc.) is held in 4 featured 13F books as of 2026 Q2. Cathie Wood - Ark Investment Management is the largest tracked holder by portfolio weight (2.3%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 2.3% (Cathie Wood - Ark Investment Management) · not free-float ownership

  1. Cathie Wood reduce 2.3%
  2. Farallon Capital Management add 1.6%
  3. Stanley Druckenmiller new 0.10%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Farallon Capital Management 2026 Q2 1.6% Add +1.0% 10,236,396 $351M history
Cathie Wood - Ark Investment Management 2026 Q2 2.3% Reduce −15.6% 10,234,862 $351M history
Stanley Druckenmiller - Duquesne Family Office 2026 Q2 0.10% New 0.10% 153,600 $5M history
Murray Stahl - Horizon Kinetics Asset Management 2026 Q2 <0.01% Reduce −4.6% 8,388 $288K history

4 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 11 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 1.02 Filing Doc
8-K 1.01,2.02,2.03,9.01 Filing Doc
10-K Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 5.02 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 12 rows shown

Filed Form Detail Links
4 Period Jul 27, 2026 Filing Doc
4 Period Jun 30, 2026 Filing Doc
4 Period Jun 29, 2026 Filing Doc
4 Period Jun 25, 2026 Filing Doc
4 Period Jun 17, 2026 Filing Doc
4 Period Jun 3, 2026 · 6 forms Filing Doc
4 Period Apr 1, 2026 · 5 forms Filing Doc
4 Period Mar 31, 2026 · 5 forms Filing Doc
4 Period Mar 30, 2026 Filing Doc
4 Period Feb 24, 2026 Filing Doc
4 Period Jan 31, 2026 Filing Doc
4 Period Jan 29, 2026 Filing Doc

Updated 4 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $377.71M $63.52M $139.74M
Net income -$132.53M -$376.74M -$79.99M
Net margin * -35.1% -593.1% -57.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.21B $0.878B $1.27B
Total non-current assets * $248.67M $225.68M $212.49M
Total assets $1.46B $1.1B $1.48B
Total current liabilities $205.56M $182.07M $96.94M
Total non-current liabilities * $272.82M $188.21M $145.88M
Total equity $0.981B $0.734B $1.24B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$149.2M -$347.25M -$345.1M
Cash from investing $71.84M $185.01M -$121.44M
Cash from financing $276.45M $7.74M $478.05M
Net change in cash $199.09M -$154.5M $11.51M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders